Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 32EISAI INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 9006256

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-1695

Delist Requested :

Patent Use Description : METHOD FOR TREATING TH...

Patent Expiration Date : 2027-07-27

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3997

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3997

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 11090386

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3519

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-23

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 11090386

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3519

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-23

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 9006256

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-1695

Delist Requested :

Patent Use Description : METHOD FOR TREATING TH...

Patent Expiration Date : 2027-07-27

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 7253286

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206947

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-24

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 7612208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206947

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-19

blank